Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Nakagawa

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|December 13, 2007
Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymesRyo C Yanagita, Yu Nakagawa, Nobuhiro Yamanaka, et al.
Bioorganic & Medicinal Chemistry|January 1, 2022
d-Mannose binding, aggregation property, and antifungal activity of amide derivatives of pradimicin AWataru Miyanishi, Makoto Ojika, Dai Akase, et al.
Developmental Biology|December 20, 2007
Fgf19 is required for zebrafish lens and retina developmentYoshiaki Nakayama, Ayumi Miyake, Yu Nakagawa, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 20, 2020
Immunohistochemistry for O<sup>6</sup>-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysisEriel Sandika Pareira, Yuki Kitano, Kentaro Ohara, et al.
Bioscience, Biotechnology, and Biochemistry|June 15, 2011
Synthesis and biological evaluation of the 12,12-dimethyl derivative of Aplog-1, an anti-proliferative analog of tumor-promoting aplysiatoxinYu Nakagawa, Masayuki Kikumori, Ryo C Yanagita, et al.
World Neurosurgery|July 2, 2017
Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive CohortYu Nakagawa, Hikaru Sasaki, Kentaro Ohara, et al.
Journal of Medicinal Chemistry|April 28, 2006
Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and etaYu Nakagawa, Kazuhiro Irie, Ryo C Yanagita, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activityRyo C Yanagita, Hiroaki Kamachi, Keisuke Tanaka, et al.
Journal of the American Chemical Society|May 20, 2009
A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activityYu Nakagawa, Ryo C Yanagita, Naoko Hamada, et al.
Bioscience, Biotechnology, and Biochemistry|May 8, 2013
Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid β aggregationMizuho Sato, Kazuma Murakami, Mayumi Uno, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 13, 2007
Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymesRyo C Yanagita, Yu Nakagawa, Nobuhiro Yamanaka, et al.
Bioorganic & Medicinal Chemistry|January 1, 2022
d-Mannose binding, aggregation property, and antifungal activity of amide derivatives of pradimicin AWataru Miyanishi, Makoto Ojika, Dai Akase, et al.
Developmental Biology|December 20, 2007
Fgf19 is required for zebrafish lens and retina developmentYoshiaki Nakayama, Ayumi Miyake, Yu Nakagawa, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 20, 2020
Immunohistochemistry for O<sup>6</sup>-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysisEriel Sandika Pareira, Yuki Kitano, Kentaro Ohara, et al.
Bioscience, Biotechnology, and Biochemistry|June 15, 2011
Synthesis and biological evaluation of the 12,12-dimethyl derivative of Aplog-1, an anti-proliferative analog of tumor-promoting aplysiatoxinYu Nakagawa, Masayuki Kikumori, Ryo C Yanagita, et al.
World Neurosurgery|July 2, 2017
Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive CohortYu Nakagawa, Hikaru Sasaki, Kentaro Ohara, et al.
Journal of Medicinal Chemistry|April 28, 2006
Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and etaYu Nakagawa, Kazuhiro Irie, Ryo C Yanagita, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activityRyo C Yanagita, Hiroaki Kamachi, Keisuke Tanaka, et al.
Journal of the American Chemical Society|May 20, 2009
A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activityYu Nakagawa, Ryo C Yanagita, Naoko Hamada, et al.
Bioscience, Biotechnology, and Biochemistry|May 8, 2013
Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid β aggregationMizuho Sato, Kazuma Murakami, Mayumi Uno, et al.
Pageof 5